Cancer Antigens

Cancer Antigens

Cancer antigens are derived from native serum, ascites, tumors, and seminal fluid. We supply recombinant forms from prostate, breast, ovarian, and gastrointestinal cancers.

Use this page as a hub to browse the available cancer antigen controls and tumor marker products below.

Available Cancer Antigen Products

• A1015: Cancer Antigen 15-3 (CA 15-3) for breast cancer biomarker and immunoassay development workflows.
• A1020: Cancer Antigen 19-9 (CA 19-9) for gastrointestinal and pancreatic cancer assay development.
• A1035: Cancer Antigen 72-4 (CA 72-4) for gastric and gastrointestinal cancer marker applications.
• A1040: Cancer Antigen 125 (CA 125) for ovarian cancer biomarker research and diagnostic development.

Contact Veritas Innovation if you need guidance selecting the right tumor marker control or require additional cancer antigen materials not listed on this page.